U.S. Agency of International Development, Arlington, VA; and.
Children's Investment Fund Foundation, Evidence Measurement and Evaluation, London, United Kingdom.
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S142-S146. doi: 10.1097/QAI.0000000000001734.
The Accelerating Children's HIV/AIDS Treatment (ACT) Initiative was an ambitious joint donor initiative to increase the number of HIV-positive children and adolescents on treatment over a 2-year period from 2014 to 2016. The funding was provided by the US Government's President's Emergency Plan for AIDS Relief (PEPFAR) and the private Children's Investment Fund Foundation (CIFF). Great gains were achieved across the 9 ACT focus countries in pediatric treatment coverage. This article assesses the status of sustainability in the ACT countries after the pediatric treatment surge using PEPFAR sustainability data and a CIFF independent evaluation of sustainability. Although a focus on treatment is critical for pediatric HIV and HIV broadly, there is also a need to support the host country ability to maintain the progress gained once donor funds and initiatives transition. It uses the case of the ACT Initiative to argue that although surge activities are successful in rapidly scaling treatment results, there are concerns related to the health system's ability to maintain the progress along the full cascade. It shares important lessons for planning for and management of transition to support future donor efforts in pediatric HIV, overall HIV programming, and broader global health initiatives.
加速儿童艾滋病治疗倡议（ACT 倡议）是一项雄心勃勃的联合捐助者倡议，旨在在 2014 年至 2016 年的两年内增加接受治疗的艾滋病毒阳性儿童和青少年的人数。资金由美国政府的总统艾滋病紧急救援计划（PEPFAR）和私人儿童投资基金基金会（CIFF）提供。ACT 倡议的 9 个重点国家在儿科治疗覆盖范围方面取得了巨大进展。本文使用 PEPFAR 可持续性数据和 CIFF 对可持续性的独立评估，评估了 ACT 国家在儿科治疗热潮后的可持续性状况。尽管关注治疗对于儿科艾滋病毒和广泛的艾滋病毒至关重要，但还需要支持所在国维持一旦捐助资金和倡议过渡后所取得进展的能力。它以 ACT 倡议为例，认为尽管激增活动在快速扩大治疗效果方面取得了成功，但人们对卫生系统维持整个治疗过程进展的能力存在担忧。它分享了规划和管理过渡的重要经验教训，以支持未来在儿科艾滋病毒、总体艾滋病毒规划以及更广泛的全球卫生倡议方面的捐助工作。
